Severe decrease in SpO2 and methemoglobinemia following subareolar isosulfan blue administration and clinical relevance

Basit Öğe Kaydı
dc.contributor.authorEsra Yüksel
dc.contributor.authorDilek Duman
dc.contributor.authorLevent Yeniay
dc.contributor.authorSezgin Ulukaya
dc.date.accessioned2019-10-26T19:27:22Z
dc.date.available2019-10-26T19:27:22Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.description.abstractThe level of axillary lymph node involvement in breast cancer is a critical decision factor for adjuvant therapy and the most important indicator of prognosis and survival. Sentinel lymph node biopsy is a minimally invasive technique with low morbidity in axillary staging of breast cancer. Radiocolloid substances (Technetium-99m) and/or blue dyes such as methylene blue or isosulfan blue are used during sentinel lymph node biopsy. Isosulfan blue stain is frequently used in sentinel lymph node biopsy and rarely causes complications. The present case report presents a severe decrease in SpO2 due to methemoglobinemia following isosulfan blue administration as well as skin and urine signs and inconsistency with clinical picture in a 67-year-old, 77 kg, ASA II female case who underwent sentinel lymph node biopsy under general anesthesia.en_US
dc.identifier.endpage76en_US
dc.identifier.issn2564-6850
dc.identifier.issue1en_US
dc.identifier.startpage74en_US
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TWprd01qWTNOdz09
dc.identifier.urihttps://hdl.handle.net/11454/10119
dc.identifier.volume34en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Surgeryen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US]
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCerrahien_US
dc.titleSevere decrease in SpO2 and methemoglobinemia following subareolar isosulfan blue administration and clinical relevanceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu